Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2014

May 6, 2014

5262_dirs_2014-05-06_6a33e632-4844-48ec-bf64-4f9a2dfc0cfb.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3799G

GlaxoSmithKline PLC

06 May 2014

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned Person Discharging Managerial Responsibility (PDMR) on 2 May 2014:

GSK Deferred Annual Bonus Plan
Dr P J T Vallance Exercise of a nil priced option over 17,569 shares and 6,993 shares granted on 24 February 2011, both of which vested on 24 February 2014 under the GlaxoSmithKline Deferred Annual Bonus Plan. GlaxoSmithKline delivered the net of tax value in shares being 13,017.

The Company and the above-mentioned PDMR were advised of this transaction on 6 May 2014.

This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

V A Whyte

Company Secretary

6 May 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSZQLFBZEFLBBD